hsa-mir-1268a: Hsa-mir-1268a is a microRNA that has been studied in various contexts. It has been found to have the potential to target TMEM175 mRNA 3'UTR, along with other microRNAs such as hsa-miR-1268b and hsa-miR-585-3p [PMC7429711]. In cardiovascular diseases and tumors, the levels of hsa-mir-1268a have been shown to change, suggesting that its expression is regulated by the pathological environment [PMC7429711]. In a study of women with gestational diabetes mellitus (GDM), hsa-mir-1268a was found to be increased in amniotic fluid [PMC7299738]. Hsa-mir-1268a has also been implicated in various diseases and conditions, such as biliary atresia and epithelial-to-mesenchymal transition (EMT) [PMC4754688] [PMC7933252]. Additionally, its expression levels have been shown to be altered in response to stimuli such as neutrophil exosomes and chromatin remodeling [PMC8484304] [PMC9556953]. Hsa-mir-1268a has also been identified as one of the dysregulated miRNAs in breast cancer cells and their exosomes [PMC7933252] [PMC4991404]. These findings highlight the potential role of hsa-mir-1268a in various biological processes and its relevance in different diseases.